Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients

Background. Gene polymorphisms affect etanercept’s pharmacokinetics, pharmacodynamics, and side effects. This effect is evidenced by the extensive genetic variation in the drug’s targets. Objectives. This study aims to find the association between different genotypes of the promoter region of the TN...

Full description

Bibliographic Details
Main Authors: Samer Imad Mohammed, Munaf Hashim Zalzala, Faiq Isho Gorial
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2023-09-01
Series:Romanian Journal of Rheumatology
Subjects:
Online Access:https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-03.pdf
_version_ 1797353858336292864
author Samer Imad Mohammed
Munaf Hashim Zalzala
Faiq Isho Gorial
author_facet Samer Imad Mohammed
Munaf Hashim Zalzala
Faiq Isho Gorial
author_sort Samer Imad Mohammed
collection DOAJ
description Background. Gene polymorphisms affect etanercept’s pharmacokinetics, pharmacodynamics, and side effects. This effect is evidenced by the extensive genetic variation in the drug’s targets. Objectives. This study aims to find the association between different genotypes of the promoter region of the TNF-α gene at -308G/A(rs1800629), -857C/T(rs1799724), -863 C/A(rs1800630), -1031 T/C (rs1799964), -806 C/T (rs4248158) and -376 G/A (rs1800750) and the side effects of ETN that occurred to Iraqi RA patients. Method. The trial included patients with rheumatoid arthritis who had been using ETN for at least six months. The participants were from the Baghdad Teaching Hospital Rheumatology Unit. The PCR was sequenced to determine the polymorphism in the TNF- promoter region at sites -308 G/A (rs1800629), -857 C/T (rs1799724), -863 C/A (rs1800630), -1031 T/C (rs1799964), and -376 G/A (rs4248158) (rs1800750). The link between the genetic variation at these loci and the etanercept’s most frequent adverse effect was then investigated. Results. The only genotype of (-376 G/A) significantly related to an increased risk of upper respiratory tract infection is the GG genotype, according to the results of this study. However, genotypes for the remaining SNPs did not demonstrate a statistically significant association between ETN and an increased risk of upper respiratory tract infections, injection site response, or skin rash in patients. Conclusion. This study revealed that only the GG genotype of (-376 G/A) was significantly associated with an elevated risk of upper respiratory tract infection.
first_indexed 2024-03-08T13:37:02Z
format Article
id doaj.art-201e4be720f04e1e97068abf41940af5
institution Directory Open Access Journal
issn 1843-0791
2069-6086
language English
last_indexed 2024-03-08T13:37:02Z
publishDate 2023-09-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Rheumatology
spelling doaj.art-201e4be720f04e1e97068abf41940af52024-01-16T15:31:52ZengAmaltea Medical Publishing HouseRomanian Journal of Rheumatology1843-07912069-60862023-09-0132311011610.37897/RJR.2023.3.3Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patientsSamer Imad Mohammed0Munaf Hashim Zalzala1Faiq Isho Gorial2Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, IraqDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Baghdad, IraqCollege of Medicine, University of Baghdad, Baghdad, IraqBackground. Gene polymorphisms affect etanercept’s pharmacokinetics, pharmacodynamics, and side effects. This effect is evidenced by the extensive genetic variation in the drug’s targets. Objectives. This study aims to find the association between different genotypes of the promoter region of the TNF-α gene at -308G/A(rs1800629), -857C/T(rs1799724), -863 C/A(rs1800630), -1031 T/C (rs1799964), -806 C/T (rs4248158) and -376 G/A (rs1800750) and the side effects of ETN that occurred to Iraqi RA patients. Method. The trial included patients with rheumatoid arthritis who had been using ETN for at least six months. The participants were from the Baghdad Teaching Hospital Rheumatology Unit. The PCR was sequenced to determine the polymorphism in the TNF- promoter region at sites -308 G/A (rs1800629), -857 C/T (rs1799724), -863 C/A (rs1800630), -1031 T/C (rs1799964), and -376 G/A (rs4248158) (rs1800750). The link between the genetic variation at these loci and the etanercept’s most frequent adverse effect was then investigated. Results. The only genotype of (-376 G/A) significantly related to an increased risk of upper respiratory tract infection is the GG genotype, according to the results of this study. However, genotypes for the remaining SNPs did not demonstrate a statistically significant association between ETN and an increased risk of upper respiratory tract infections, injection site response, or skin rash in patients. Conclusion. This study revealed that only the GG genotype of (-376 G/A) was significantly associated with an elevated risk of upper respiratory tract infection.https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-03.pdfadverse effectsetanerceptrheumatoid arthritisgenetic polymorphismtnf-α
spellingShingle Samer Imad Mohammed
Munaf Hashim Zalzala
Faiq Isho Gorial
Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
Romanian Journal of Rheumatology
adverse effects
etanercept
rheumatoid arthritis
genetic polymorphism
tnf-α
title Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
title_full Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
title_fullStr Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
title_full_unstemmed Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
title_short Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
title_sort association between genetic polymorphism in tumor necrosis factor alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
topic adverse effects
etanercept
rheumatoid arthritis
genetic polymorphism
tnf-α
url https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-03.pdf
work_keys_str_mv AT samerimadmohammed associationbetweengeneticpolymorphismintumornecrosisfactoralphageneandadverseeffectsofetanerceptinrheumatoidarthritispatients
AT munafhashimzalzala associationbetweengeneticpolymorphismintumornecrosisfactoralphageneandadverseeffectsofetanerceptinrheumatoidarthritispatients
AT faiqishogorial associationbetweengeneticpolymorphismintumornecrosisfactoralphageneandadverseeffectsofetanerceptinrheumatoidarthritispatients